BMSSC
ALXN

B. Metzler seel. Sohn & Co’s Alexion Pharmaceuticals ALXN Stock Holding History

B. Metzler seel. Sohn & Co’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-6,425
Closed -$1.18M – 724
2021
Q2 		$1.18M Buy
6,425
+103
+2% +$17.7K 0.02% 401
2021
Q1 		$967K Sell
6,322
-1,513
-19% -$234K 0.02% 420
2020
Q4 		$1.24M Buy
+7,835
New +$1.01M 0.02% 358

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return

B. Metzler seel. Sohn & Co's ALXN Position: Q3 2021 in Review

B. Metzler seel. Sohn & Co sold out of Alexion Pharmaceuticals (ALXN) in Q3 2021, closing a stake of 6,425 shares — an estimated $1.18M sold.

B. Metzler seel. Sohn & Co first reported a position in ALXN in Q4 2020 and held it in 3 quarters. The position peaked at $1.24M in Q4 2020. 7 funds tracked by Wall St. Rank hold ALXN as of Q3 2021.

  • B. Metzler seel. Sohn & Co reported no remaining Alexion Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • B. Metzler seel. Sohn & Co sold 6,425 Alexion Pharmaceuticals shares in Q3 2021, an estimated $1.18M.
  • B. Metzler seel. Sohn & Co first reported a position in Alexion Pharmaceuticals in Q4 2020 and held it in 3 quarters.
  • B. Metzler seel. Sohn & Co's Alexion Pharmaceuticals position peaked at $1.24M in Q4 2020.
  • 7 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q3 2021.

Based on B. Metzler seel. Sohn & Co's 13F filing for Q3 2021, filed 1 Nov 2021.